Barclays
CNTB

Barclays’s Connect Biopharma Holdings CNTB Stock Holding History

Barclays’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.85K Buy
+2,879
New +$6.98K ﹤0.01% 4747
2022
Q2 		– Sell
-313,732
Closed -$947K – 5054
2022
Q1 		$947K Buy
+313,732
New +$1.32M ﹤0.01% 2455

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Barclays's CNTB Position: Q2 2026 in Review

Barclays opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 2,879 shares worth $6.85K. The stake represents ﹤0.01% of the portfolio and ranks #4747 among its holdings. This is a return to the name: Barclays previously reported a position in CNTB as recently as Q1 2022.

Barclays first reported a position in CNTB in Q1 2022 and has held it in 2 quarters since. The position peaked at $947K in Q1 2022. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Barclays held 2,879 shares of Connect Biopharma Holdings worth $6.85K as of Q2 2026.
  • Connect Biopharma Holdings was a new Barclays position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4747 holding.
  • Barclays first reported a position in Connect Biopharma Holdings in Q1 2022 and has held it in 2 quarters since.
  • Barclays's Connect Biopharma Holdings position peaked at $947K in Q1 2022.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.